Therapeutic impact of vildagliptin vs. gliclazide on insulin resistance and advanced glycated end product levels in newly diagnosed Egyptian diabetics: a randomized controlled trial. [PDF]
Eur J Clin PharmacolElemary T +3 more
europepmc +1 more source
Vildagliptin modulates the microbiota and induces an immunometabolic profile compatible with neuroprotection in type 2 diabetes. [PDF]
Sci Repde Macedo JCC +9 more
europepmc +1 more source
Vildagliptin and its Association with Bullous Pemphigoid. [PDF]
Ann Afr MedMeah A, Reddy KS, Rajeshwari KA.
europepmc +1 more source
The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy. [PDF]
Front Endocrinol (Lausanne)Kong D +7 more
europepmc +1 more source
Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. [PDF]
Sci RepSedik AA +3 more
europepmc +1 more source
Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study. [PDF]
Psychol MedHo MTH +9 more
europepmc +1 more source
Effects of Dapagliflozin vs. Vildagliptin on the Lipid Profile of Patients With Uncontrolled Type 2 Diabetes. [PDF]
CureusKhanna S, Malik M, Ahmad R.
europepmc +1 more source
Comment on "SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis" critical considerations on biomarker validation and Supraphysiological drug concentrations. [PDF]
J Transl MedChen J, Yan L.
europepmc +1 more source
<i>Candida glabrata</i> Prostatitis: A Rare Case in a Patient With Type 2 Diabetes Mellitus on Dapagliflozin Treatment. [PDF]
Case Rep Infect DisTorres García EG +4 more
europepmc +1 more source
Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets. [PDF]
J Comput Aided Mol DesInglot TW.
europepmc +1 more source